Financial News

Financial Report: Johnson & Johnson

Pharmaceutical sales were $10.4 billion in the quarter, up 20%

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Johnson & Johnson 2Q Revenues: $20.8 billion (+11%) 2Q Earnings: $4.0 billion (+3%) YTD Revenues: $40.8 billion (+12%) YTD Earnings: $8.3 billion (+1%) Comments: Worldwide Pharmaceutical sales were $10.4 billion in the quarter, up 20%. Domestic sales increased 18% and international sales increased 23%. Sales included the impact of Actelion Ltd. which contributed 6.6%, to worldwide operational sales growth. Growth was driven by Stelara, up 36% to $1.3 billion; Zytiga up 63% to $909 milli...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters